• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征大鼠肠道微生物群和代谢物的多组学分析。

Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.

机构信息

Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Department of Gastroenterology, Beijing Friendship Hospital, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Capital Medical University, Beijing, China.

Department of Operations and Information Management, China-Japan Friendship Hospital, Beijing, China.

出版信息

Front Cell Infect Microbiol. 2019 May 29;9:178. doi: 10.3389/fcimb.2019.00178. eCollection 2019.

DOI:10.3389/fcimb.2019.00178
PMID:31192167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6549239/
Abstract

Irritable bowel syndrome (IBS) is a common gastrointestinal dysfunctional disease. The pathophysiology of IBS is, however, largely unknown. This study aimed to determine whether evaluation of fecal metabolite and microbiota profiles may offer an opportunity to identify a novel pathophysiological target for IBS, and to reveal possible gut microbe-metabolite associations. By using gas chromatography coupled to time-of-flight mass spectrometry (GC-TOFMS) and 16S rRNA gene sequencing, we measured fecal metabolites and microbiota of the control and water avoidance stress (WAS)-induced IBS rats. We found a significantly differential metabolite profile between the IBS and control groups; a cluster of metabolites was also found to be significantly associated with the amount of defecations. Moreover, the WAS group exhibited a decreased alpha diversity of the microbial population as compared to the control group. However, the characteristics of gut microbiota could not differentiate the IBS group from the control group. Correlation of the metabolite level with the number of microbial genera showed no significant association between the control and IBS groups. This study provides a global perspective on metabolomics and microbiota profiling in WAS-induced IBS model and a theoretical basis for research on the pathophysiology of IBS.

摘要

肠易激综合征(IBS)是一种常见的胃肠道功能紊乱疾病。然而,IBS 的病理生理学在很大程度上是未知的。本研究旨在确定评估粪便代谢物和微生物群谱是否为 IBS 提供了一个新的病理生理靶点的机会,并揭示可能的肠道微生物-代谢物关联。通过使用气相色谱-飞行时间质谱联用(GC-TOFMS)和 16S rRNA 基因测序,我们测量了对照组和水回避应激(WAS)诱导的 IBS 大鼠的粪便代谢物和微生物群。我们发现 IBS 组和对照组之间存在明显不同的代谢物谱;一组代谢物也与粪便量显著相关。此外,与对照组相比,WAS 组的微生物种群的 alpha 多样性降低。然而,肠道微生物群的特征不能将 IBS 组与对照组区分开来。代谢物水平与微生物属数量的相关性表明,对照组和 IBS 组之间没有显著关联。本研究提供了 WAS 诱导的 IBS 模型中代谢组学和微生物组学分析的全局视角,并为 IBS 病理生理学的研究提供了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/23e5f08774df/fcimb-09-00178-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/abfaed90456b/fcimb-09-00178-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/36707f4e3b4f/fcimb-09-00178-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/f807bf14a7fd/fcimb-09-00178-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/7e00126ed71d/fcimb-09-00178-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/23e5f08774df/fcimb-09-00178-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/abfaed90456b/fcimb-09-00178-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/36707f4e3b4f/fcimb-09-00178-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/f807bf14a7fd/fcimb-09-00178-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/7e00126ed71d/fcimb-09-00178-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c016/6549239/23e5f08774df/fcimb-09-00178-g0005.jpg

相似文献

1
Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.肠易激综合征大鼠肠道微生物群和代谢物的多组学分析。
Front Cell Infect Microbiol. 2019 May 29;9:178. doi: 10.3389/fcimb.2019.00178. eCollection 2019.
2
Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.识别肠微生物组和代谢产物特征在肠易激综合征患者中。
Front Cell Infect Microbiol. 2019 Oct 18;9:346. doi: 10.3389/fcimb.2019.00346. eCollection 2019.
3
Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome.基于气相色谱/质谱联用代谢组学的肠易激综合征小鼠模型研究。
World J Gastroenterol. 2018 Feb 28;24(8):894-904. doi: 10.3748/wjg.v24.i8.894.
4
Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.肠道微生物组-代谢组综合特征反映了肠易激综合征中的应激和 5-羟色胺代谢。
Gut Microbes. 2022 Jan-Dec;14(1):2063016. doi: 10.1080/19490976.2022.2063016.
5
Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.腹泻型肠易激综合征患者对粪便微生物群移植的临床反应与粪便微生物群组成和短链脂肪酸水平的正常化有关。
Scand J Gastroenterol. 2019 Jun;54(6):690-699. doi: 10.1080/00365521.2019.1624815. Epub 2019 Jun 13.
6
Integrative analysis of the gut microbiome and metabolome in a rat model with stress induced irritable bowel syndrome.应激诱导肠易激综合征大鼠模型的肠道微生物组和代谢组的综合分析。
Sci Rep. 2021 Sep 2;11(1):17596. doi: 10.1038/s41598-021-97083-z.
7
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.利福昔明治疗对肠易激综合征相关粪便微生物组和代谢组差异的有限长期影响。
Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26.
8
Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.肠易激综合征及其肠道习惯亚型的肠道微生物组的多组学特征。
Microbiome. 2023 Jan 10;11(1):5. doi: 10.1186/s40168-022-01450-5.
9
The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome.健康状态和肠易激综合征患者的人体肠道微生物-代谢物关联网络存在差异。
ISME J. 2015 Aug;9(8):1899-903. doi: 10.1038/ismej.2014.258. Epub 2015 Jan 30.
10
A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.与肠易激综合征患者排便习惯相关的独特粪便微生物群和代谢物特征。
Cells. 2021 Jun 10;10(6):1459. doi: 10.3390/cells10061459.

引用本文的文献

1
Multi-Omics Analysis to Generate Hypotheses for Mild Health Problems in Monkeys.多组学分析以生成关于猴子轻度健康问题的假设
Metabolites. 2021 Oct 13;11(10):701. doi: 10.3390/metabo11100701.
2
Dysbiosis in the Gut Microbiome in Streptozotocin-Induced Diabetes Rats and Follow-Up During Retinal Changes.肠道微生物组在链脲佐菌素诱导的糖尿病大鼠中的失调及在视网膜病变期间的后续变化。
Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):31. doi: 10.1167/iovs.62.10.31.
3
approaches for studying the microbiome in Alopecia areata.研究斑秃微生物组的方法。

本文引用的文献

1
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.肠易激综合征患者的肠道微生物群:系统评价。
Gastroenterology. 2019 Jul;157(1):97-108. doi: 10.1053/j.gastro.2019.03.049. Epub 2019 Mar 30.
2
Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers.比较肠易激综合征患者、溃疡性结肠炎患者和健康对照者的代谢组学特征:对病理生理学和潜在生物标志物的新认识。
Aliment Pharmacol Ther. 2019 Mar;49(6):723-732. doi: 10.1111/apt.15141. Epub 2019 Jan 31.
3
Pre- and probiotic overview.
J Investig Med. 2020 Oct;68(7):1292-1294. doi: 10.1136/jim-2020-001426. Epub 2020 Sep 21.
4
Role of gut microbiota in identification of novel TCM-derived active metabolites.肠道微生物群在鉴定新型中药来源的活性代谢物中的作用。
Protein Cell. 2021 May;12(5):394-410. doi: 10.1007/s13238-020-00784-w. Epub 2020 Sep 15.
5
Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.识别肠微生物组和代谢产物特征在肠易激综合征患者中。
Front Cell Infect Microbiol. 2019 Oct 18;9:346. doi: 10.3389/fcimb.2019.00346. eCollection 2019.
益生菌和益生元概述。
Curr Opin Pharmacol. 2018 Dec;43:87-92. doi: 10.1016/j.coph.2018.08.010. Epub 2018 Sep 13.
4
Transcriptome and methylome profiling in a rat model of irritable bowel syndrome induced by stress.应激诱导的肠易激综合征大鼠模型的转录组和甲基组分析。
Int J Mol Med. 2018 Nov;42(5):2641-2649. doi: 10.3892/ijmm.2018.3823. Epub 2018 Aug 14.
5
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝炎发生过程中肠道微生物组和代谢组的动态变化。
World J Gastroenterol. 2018 Jun 21;24(23):2468-2481. doi: 10.3748/wjg.v24.i23.2468.
6
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.粪便梭状芽胞杆菌分布和短链脂肪酸反映肠易激综合征的排便习惯。
Environ Microbiol. 2018 Sep;20(9):3201-3213. doi: 10.1111/1462-2920.14271. Epub 2018 Sep 24.
7
Hot-water extract of the branches of Thunb. (Rhamnaceae) ameliorates low-fiber diet-induced constipation in rats.鼠李科鼠李属植物鼠李枝条的热水提取物可改善低纤维饮食诱导的大鼠便秘。
Drug Des Devel Ther. 2018 Apr 3;12:695-703. doi: 10.2147/DDDT.S150284. eCollection 2018.
8
Gut Microbiota in Health and Disease.肠道微生物群与健康和疾病。
Ann Nutr Metab. 2017;71(3-4):242-246. doi: 10.1159/000481627. Epub 2017 Nov 14.
9
Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment.肠易激综合征:流行病学、病理生理学、诊断与治疗
Prim Care. 2017 Dec;44(4):655-671. doi: 10.1016/j.pop.2017.07.009. Epub 2017 Oct 5.
10
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.健康、憩室病、肠易激综合征及炎症性肠病中的肠道微生物群:是时候寻找胃肠道疾病的微生物标志物了。
Dig Dis. 2018;36(1):56-65. doi: 10.1159/000477205. Epub 2017 Jul 7.